Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lung Neoplasms × Cetuximab × Clear all

Phase

Status

Completed 15 Recruiting 7 Terminated 2 Active not recruiting 2 Withdrawn 1 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 40 Rectal Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 9 Neoplasm Metastasis 9 Colonic Neoplasms 9 Head and Neck Neoplasms 6 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma 3 Uterine Cervical Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Colorectal Cancer Metastatic 2 Carcinoma, Squamous Cell 2 Breast Neoplasms 2 Adenocarcinoma Of Esophagus 2 mCRC 1 Stomach Neoplasms 1 Skin Neoplasms 1 Recurrence 1 Patients With Advanced or Metastatic Solid Tumors 1 Neoplasms, Unknown Primary 1 Nasopharyngeal Neoplasms 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Metastasis Colon Cancer 1 Incurable Colorectal Cancer 1 Glioblastoma 1

Interventions

Cisplatin 35 Carboplatin 20 Gemcitabine 19 Radiotherapy 17 Docetaxel 17 Etoposide 16 Paclitaxel 11 Erlotinib Hydrochloride 11 Vinorelbine 9 Gefitinib 8 Drug Therapy 8 endostar protein 7 apatinib 7 Blood Specimen Collection 7 pembrolizumab 6 aumolertinib 6 Thoracic Surgery, Video-Assisted 6 osimertinib 5 durvalumab 5 Vinblastine 5 Surgical Procedures, Operative 5 Fluorodeoxyglucose F18 5 Cyclophosphamide 5 sintilimab 4 Pemetrexed 4 Hematologic Tests 4 Chemotherapy, Adjuvant 4 anlotinib 3 Tomography, X-Ray Computed 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06101394 2024-01-25

RECOGNISE

University of Turin, Italy

Phase 2 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡